Found: 66
Select item for more details and to access through your institution.
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations.
- Published in:
- Patient Preference & Adherence, 2024, v. 18, p. 1845, doi. 10.2147/PPA.S468705
- By:
- Publication type:
- Article
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1207, doi. 10.3390/ph14121207
- By:
- Publication type:
- Article
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09934-2
- By:
- Publication type:
- Article
Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.
- Published in:
- Liver International, 2013, v. 33, n. 4, p. 624, doi. 10.1111/liv.12100
- By:
- Publication type:
- Article
Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.
- Published in:
- Liver International, 2013, v. 33, n. 4, p. 569, doi. 10.1111/liv.12050
- By:
- Publication type:
- Article
Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 1117, doi. 10.2147/PPA.S405567
- By:
- Publication type:
- Article
Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory Study.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 2649, doi. 10.2147/PPA.S341566
- By:
- Publication type:
- Article
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC).
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 599, doi. 10.2147/PPA.S236818
- By:
- Publication type:
- Article
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 3, p. 439, doi. 10.1159/000527784
- By:
- Publication type:
- Article
Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases.
- Published in:
- Digestive Diseases, 2010, v. 28, n. 1, p. 186, doi. 10.1159/000282084
- By:
- Publication type:
- Article
An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 6, p. 1, doi. 10.1111/dme.14799
- By:
- Publication type:
- Article
Causes and Consequences of Innate Immune Dysfunction in Cirrhosis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00293
- By:
- Publication type:
- Article
Ascites Bacterial Burden and Immune Cell Profile Are Associated with Poor Clinical Outcomes in the Absence of Overt Infection.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120642
- By:
- Publication type:
- Article
Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians.
- Published in:
- International Journal for Equity in Health, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12939-020-1144-6
- By:
- Publication type:
- Article
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
- Published in:
- Journal of Magnetic Resonance Imaging, 2008, v. 28, n. 4, p. 937, doi. 10.1002/jmri.21542
- By:
- Publication type:
- Article
Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 6, p. 961, doi. 10.1111/imj.15854
- By:
- Publication type:
- Article
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 5, p. 691, doi. 10.1111/imj.14809
- By:
- Publication type:
- Article
Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 9, p. 1142, doi. 10.1111/imj.14986
- By:
- Publication type:
- Article
Haemochromatosis: a clinical update for the practising physician.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 5, p. 509, doi. 10.1111/imj.13784
- By:
- Publication type:
- Article
Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 2, p. 144, doi. 10.1111/imj.13667
- By:
- Publication type:
- Article
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 8, p. 952, doi. 10.1111/imj.13505
- By:
- Publication type:
- Article
Corrigendum: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Can paracetamol (acetaminophen) be administered to patients with liver impairment?
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 2, p. 210, doi. 10.1111/bcp.12802
- By:
- Publication type:
- Article
Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.
- Published in:
- Fibrogenesis & Tissue Repair, 2015, v. 8, p. 1, doi. 10.1186/s13069-015-0036-7
- By:
- Publication type:
- Article
The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
- Published in:
- Liver International, 2016, v. 36, n. 3, p. 370, doi. 10.1111/liv.12896
- By:
- Publication type:
- Article
Response to ELF cut-off points: aetiology is also a relevant factor.
- Published in:
- Liver International, 2015, v. 35, n. 7, p. 1921, doi. 10.1111/liv.12822
- By:
- Publication type:
- Article
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.
- Published in:
- Liver International, 2015, v. 35, n. 6, p. 1673, doi. 10.1111/liv.12760
- By:
- Publication type:
- Article
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 4, p. 873, doi. 10.1111/jgh.15175
- By:
- Publication type:
- Article
Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Unusual Iron and Copper Studies in a Patient with Liver Injury and Normocytic Anemia.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 2, p. 277, doi. 10.1093/clinchem/hvz001
- By:
- Publication type:
- Article
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 605, doi. 10.1007/s40801-023-00390-2
- By:
- Publication type:
- Article
Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 496, p. N.PAG, doi. 10.1126/scitranslmed.aat9284
- By:
- Publication type:
- Article
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2023, v. 28, n. 6, p. 1, doi. 10.1016/j.aohep.2023.101142
- By:
- Publication type:
- Article
Recognition of Genetic Factors Influencing the Progression of Hepatitis C.
- Published in:
- Molecular Diagnosis & Therapy, 2008, v. 12, n. 4, p. 209, doi. 10.1007/BF03256286
- By:
- Publication type:
- Article
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82315-z
- By:
- Publication type:
- Article
Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0167001
- By:
- Publication type:
- Article
Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157771
- By:
- Publication type:
- Article
Crosses of NOD mice with the related NON strain. A polygenic model for IDDM.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
- Published in:
- Medical Journal of Australia, 2023, v. 219, n. 8, p. 358, doi. 10.5694/mja2.52104
- By:
- Publication type:
- Article
Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
- Published in:
- Medical Journal of Australia, 2023, v. 219, p. 358, doi. 10.5694/mja2.52104
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease: raising awareness of a looming public health problem.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Khat-associated hepatitis.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2809, doi. 10.3390/biomedicines11102809
- By:
- Publication type:
- Article
CASE REPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.
- Published in:
- Journal of Gastroenterology & Hepatology, 1999, v. 14, n. 8, p. 801, doi. 10.1046/j.1440-1746.1999.01961.x
- By:
- Publication type:
- Article
Successful in vitro fertilization and pregnancy in a patient with autoimmune chronic active hepatitis and cirrhosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 1995, v. 10, n. 2, p. 233, doi. 10.1111/j.1440-1746.1995.tb01084.x
- By:
- Publication type:
- Article
Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism.
- Published in:
- Journal of Gastroenterology & Hepatology, 1992, v. 7, n. 2, p. 214, doi. 10.1111/j.1440-1746.1992.tb00965.x
- By:
- Publication type:
- Article
Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 1992, v. 7, n. 2, p. 225, doi. 10.1111/j.1440-1746.1992.tb00966.x
- By:
- Publication type:
- Article